Exosomes as novel biomarkers in metabolic disease and obesity-related cancers.

Nat Rev Endocrinol

Boston University-Boston Medical Center Cancer Center, Boston University School of Medicine, Boston, MA, USA.

Published: June 2022

Exosomes include plasma-transported vesicles that are secreted by human tissues and reflect metabolic status. The profile of exosomes (particularly microRNA content) is altered in metabolic disease. In type 2 diabetes mellitus, exosomes circulating in plasma induce transcriptional changes related to tumour progression and pro-metastatic phenotypes in target cancer cells, potentially linking obesity to cancer progression and metastasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152991PMC
http://dx.doi.org/10.1038/s41574-022-00666-7DOI Listing

Publication Analysis

Top Keywords

metabolic disease
8
exosomes
4
exosomes novel
4
novel biomarkers
4
biomarkers metabolic
4
disease obesity-related
4
obesity-related cancers
4
cancers exosomes
4
exosomes include
4
include plasma-transported
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!